TREACE JOHN T. (Chief Executive Officer) purchased 1.6% of their position (115.52K shares) of TREACE MEDICAL CONCEPTS, INC. on the open market
Open‑market purchase worth $340.6K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 5/28/2026ACC: 0001193125-26-245341
DirectorOfficer10% Owner· Chief Executive Officer
Since Apr 2021
+115.52K
Net shares
Net buyer
$340.6K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
115.52K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+4.51K
Price / share
$2.79
Trade value
$12.58K
% of position
0.1%
5/26/2026
7.16M→7.16M
Common Stock
Direct
Shares
+49.81K
Price / share
$2.87
Trade value
$143.19K
% of position
0.7%
5/27/2026
7.16M→7.21M
Common Stock
Direct
Shares
+61.20K
Price / share
$3.02
Trade value
$184.82K
% of position
0.8%
5/28/2026
7.21M→7.27M
Total
Net shares
+115.52K
Net value
$340.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/26/2026 | P · Purchase | +4.51K | $2.79 | $12.58K | 0.1% | 7.16M | 7.16M |
| Common Stock Direct | 5/27/2026 | P · Purchase | +49.81K | $2.87 | $143.19K | 0.7% | 7.16M | 7.21M |
| Common Stock Direct | 5/28/2026 | P · Purchase | +61.20K | $3.02 | $184.82K | 0.8% | 7.21M | 7.27M |
| Total | +115.52K | $340.59K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned408.82K
Common Stock
IndirectShares owned1.60M
Common Stock
IndirectShares owned1.47M
Common Stock
IndirectShares owned1.84M
Total
5.32M indirect5.32M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 408.82K | Indirect |
| Common Stock | 1.60M | Indirect |
| Common Stock | 1.47M | Indirect |
| Common Stock | 1.84M | Indirect |
| Total | 5.32M | 5.32M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported